Related Experiment Videos
Hepatocirculatory failure: diverse pathogeneses deserve diverse therapies
1University of Minnesota Medical School, Minneapolis 55455.
Hepatology (Baltimore, Md.)
|March 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.
Journal of human hypertension·2005
Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).
Vascular medicine (London, England)·2002
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
The New England journal of medicine·2002
ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implications.
Heart disease (Hagerstown, Md.)·2001
Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.
Hepatology (Baltimore, Md.)·2026
Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.
Hepatology (Baltimore, Md.)·2026
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.)·2026